J Michael Dixon Selected Research

Capsules (Microcapsules)

8/2013

Evaluation of the pharmacodynamics and pharmacokinetics of the PARP inhibitor olaparib: a phase I multicentre trial in patients scheduled for elective breast cancer surgery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Michael Dixon Research Topics

Disease

77	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2002
61	Neoplasms (Cancer) 10/2023 - 01/2002
6	Neoplasm Metastasis (Metastasis) 11/2020 - 05/2006
5	Noninfiltrating Intraductal Carcinoma (DCIS) 11/2017 - 08/2007
3	Margins of Excision 01/2023 - 12/2010
3	Lobular Carcinoma 01/2018 - 12/2011
2	Triple Negative Breast Neoplasms 03/2024 - 12/2015
2	Disease Progression 01/2021 - 07/2006
1	COVID-19 01/2020
1	Insulin Resistance 01/2019
1	Obesity 01/2019
1	Inflammatory Breast Neoplasms 12/2018
1	Erythema 12/2018
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2018
1	Pathologic Complete Response 06/2017
1	Hypoxia (Hypoxemia) 09/2015
1	Carcinoma (Carcinomatosis) 09/2015
1	Thymoma (Thymic Carcinoma) 03/2015
1	Ductal Carcinoma 10/2014
1	Asthenia 08/2013
1	Procedural Pain 08/2013
1	Nausea 08/2013
1	Bone Resorption 02/2010

Drug/Important Bio-Agent (IBA)

31	Estrogen ReceptorsIBA 01/2022 - 01/2002
23	Letrozole (Femara)FDA LinkGeneric 01/2020 - 06/2002
23	Tamoxifen FDA LinkGeneric 01/2012 - 01/2002
21	Aromatase InhibitorsIBA 01/2019 - 06/2002
16	Hormones (Hormone)IBA 01/2023 - 01/2002
14	Estrogens (Estrogen)FDA Link 01/2017 - 06/2002
14	Anastrozole (Arimidex)FDA LinkGeneric 03/2013 - 06/2002
12	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2004
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2008
6	exemestane (Aromasin)FDA Link 01/2020 - 03/2002
5	Aromatase (CYP19)IBA 01/2019 - 06/2002
4	Everolimus FDA Link 01/2013 - 06/2009
3	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2008
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2009
3	Fulvestrant (Faslodex)FDA Link 01/2020 - 03/2013
3	Progesterone Receptors (Progesterone Receptor)IBA 12/2015 - 04/2005
3	Estradiol (Delestrogen)FDA LinkGeneric 08/2012 - 04/2008
2	CytokinesIBA 10/2021 - 06/2021
2	Cytokine Receptor gp130IBA 10/2021 - 06/2021
2	Phenobarbital (Luminal)FDA Link 05/2021 - 07/2011
2	Cadherins (E-Cadherin)IBA 01/2021 - 10/2014
2	human ERBB2 proteinIBA 01/2019 - 08/2005
2	Messenger RNA (mRNA)IBA 01/2017 - 05/2014
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017 - 04/2005
2	Estrogen Receptor alphaIBA 07/2015 - 12/2006
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2013 - 04/2010
2	ClaudinsIBA 03/2011 - 08/2009
2	Estrone FDA Link 01/2010 - 04/2008
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 02/2009 - 01/2002
1	Insulin-Like Growth Factor I (IGF-1)IBA 02/2022
1	Conditioned Culture MediaIBA 08/2021
1	palbociclibIBA 05/2021
1	Ado-Trastuzumab EmtansineIBA 05/2021
1	neratinibIBA 05/2021
1	SteroidsIBA 01/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	AZD9496IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Aromatase deficiencyIBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	LeptinIBA 01/2019
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 11/2018
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	NeuregulinsIBA 01/2017
1	LigandsIBA 01/2017
1	Neuregulin-1 (Neuregulin 1)IBA 01/2017
1	Estrogen Receptor Modulators (Antiestrogen)IBA 12/2015
1	sulfamic acid (ammonium sulfamate)IBA 09/2015
1	Carbonic Anhydrase IXIBA 09/2015
1	olaparibIBA 08/2013
1	Capsules (Microcapsules)IBA 08/2013
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2013
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2013
1	CreatinineIBA 08/2013
1	Holliday Junction ResolvasesIBA 03/2013
1	estrone sulfate (Evex)FDA Link 08/2012
1	CollagenIBA 01/2012
1	Phosphotransferases (Kinase)IBA 02/2011
1	Eukaryotic Initiation Factor-4EIBA 02/2011
1	Sirolimus (Rapamycin)FDA Link 02/2011
1	Cell-Free Nucleic AcidsIBA 04/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2010
1	Celecoxib (Celebrex)FDA Link 03/2010
1	EnzymesIBA 01/2010

Therapy/Procedure

59	Therapeutics 10/2023 - 01/2002
21	Neoadjuvant Therapy 11/2020 - 03/2002
11	Radiotherapy 01/2023 - 05/2006
10	Drug Therapy (Chemotherapy) 03/2024 - 01/2002
9	Segmental Mastectomy (Lumpectomy) 01/2023 - 01/2004
7	Mastectomy (Mammectomy) 10/2019 - 01/2004
4	Adjuvant Chemotherapy 01/2020 - 08/2008
1	Lasers (Laser) 02/2022
1	Contraindications 12/2018
1	Breast Implants (Breast Implant) 11/2018
1	Immunotherapy 12/2015
1	Aftercare (After-Treatment) 09/2015
1	Mammaplasty (Breast Reconstruction) 09/2012